First Trust Direct Indexing’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-33,089
| Closed | -$2.77M | – | 363 |
|
|
2024
Q3 | $2.77M | Buy |
33,089
+4,019
| +14% | +$337K | 0.15% | 129 |
|
|
2024
Q2 | $1.99M | Buy |
29,070
+1,747
| +6% | +$120K | 0.12% | 165 |
|
|
2024
Q1 | $2M | Sell |
27,323
-2,834
| -9% | -$208K | 0.15% | 143 |
|
|
2023
Q4 | $2.44M | Buy |
30,157
+5,648
| +23% | +$458K | 0.22% | 100 |
|
|
2023
Q3 | $1.84M | Sell |
24,509
-1,679
| -6% | -$126K | 0.21% | 109 |
|
|
2023
Q2 | $2.02M | Sell |
26,188
-800
| -3% | -$61.7K | 0.22% | 97 |
|
|
2023
Q1 | $2.24M | Buy |
26,988
+1,052
| +4% | +$87.3K | 0.27% | 83 |
|
|
2022
Q4 | $2.23M | Buy |
25,936
+5,041
| +24% | +$433K | 0.3% | 73 |
|
|
2022
Q3 | $1.29M | Buy |
20,895
+1,612
| +8% | +$99.4K | 0.19% | 130 |
|
|
2022
Q2 | $1.19M | Buy |
19,283
+4,187
| +28% | +$259K | 0.17% | 159 |
|
|
2022
Q1 | $897K | Buy |
15,096
+783
| +5% | +$46.5K | 0.11% | 240 |
|
|
2021
Q4 | $1.04M | Sell |
14,313
-43
| -0.3% | -$3.12K | 0.13% | 180 |
|
|
2021
Q3 | $1M | Buy |
14,356
+2,071
| +17% | +$145K | 0.14% | 171 |
|
|
2021
Q2 | $846K | Buy |
12,285
+1,494
| +14% | +$103K | 0.13% | 204 |
|
|
2021
Q1 | $697K | Buy |
10,791
+1,012
| +10% | +$65.4K | 0.19% | 158 |
|
|
2020
Q4 | $570K | Buy |
+9,779
| New | +$570K | 0.15% | 166 |
|